Spatiotemporal distribution of SUMOylation components during mouse brain development

Journal of Comparative Neurology

Volumn 522, Issue 13, 2014, Pages 3020-3036

  Hasegawa, Yuta ^a   Yoshida, Daisuke ^a   Nakamura, Yuki ^a   Sakakibara, Shin Ichi ^a  

^a WASEDA UNIVERSITY   (Japan)

Author keywords

Brain development; Neural progenitor cell; SUMO1; SUMO2 3; Ubc9

Indexed keywords

NESTIN; PROTEIN UBC9; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; NERVE PROTEIN; SUMO PROTEIN; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN-CONJUGATING ENZYME UBC9;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN NERVE CELL; BRAIN STEM; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO DEVELOPMENT; HIPPOCAMPUS; MOUSE; NERVE PROJECTION; NEURAL STEM CELL; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SUBVENTRICULAR ZONE; SUMOYLATION; ANIMAL; ANIMAL EMBRYO; BRAIN; CELL CULTURE; CYTOLOGY; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; INSTITUTE FOR CANCER RESEARCH MOUSE; LATERAL BRAIN VENTRICLE; METABOLISM; NEWBORN; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CELLS, CULTURED; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LATERAL VENTRICLES; MICE; MICE, INBRED ICR; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; UBIQUITIN-CONJUGATING ENZYMES;

EID: 84903973595     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23563     Document Type: Article

References (56)

1. Ayaydin F, Dasso M. 2004. Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol Biol Cell 15:5208-5218.
2. Bettermann K, Benesch M, Weis S, Haybaeck J. 2012. SUMOylation in carcinogenesis. Cancer Lett 316:113-125.
3. Bruderer R, Tatham MH, Plechanovova A, Matic I, Garg AK, Hay RT. 2011. Purification and identification of endogenous polySUMO conjugates. EMBO Rep 12:142-148.
4. Cai N, Li M, Qu J, Liu GH, Izpisua Belmonte JC. 2012. Post-translational modulation of pluripotency. J Mol Cell Biol 4:262-265.
5. Chamberlain SE, Gonzalez-Gonzalez IM, Wilkinson KA, Konopacki FA, Kantamneni S, Henley JM, Mellor JR. 2012. SUMOylation and phosphorylation of GluK2 regulate kainate receptor trafficking and synaptic plasticity. Nat Neurosci 15:845-852.
6. Demarque MD, Nacerddine K, Neyret-Kahn H, Andrieux A, Danenberg E, Jouvion G, Bomme P, Hamard G, Romagnolo B, Terris B, Cumano A, Barker N, Clevers H, Dejean A. 2011. Sumoylation by Ubc9 regulates the stem cell compartment and structure and function of the intestinal epithelium in mice. Gastroenterology 140:286-296.
7. Driscoll JJ, Pelluru D, Lefkimmiatis K, Fulciniti M, Prabhala RH, Greipp PR, Barlogie B, Tai YT, Anderson KC, Shaughnessy JD Jr, Annunziata CM, Munshi NC. 2010. The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome. Blood 115:2827-2834.
8. Evdokimov E, Sharma P, Lockett SJ, Lualdi M, Kuehn MR. 2008. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3. J Cell Sci 121:4106-4113.
9. Gocke CB, Yu H, Kang J. 2005. Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. J Biol Chem 280:5004-5012.
10. Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S, Podolsky RH, Muir A, Wang J, Dong Z, Brusko T, Atkinson M, Pozzilli P, Zeidler A, Raffel LJ, Jacob CO, Park Y, Serrano-Rios M, Larrad MT, Zhang Z, Garchon HJ, Bach JF, Rotter JI, She JX, Wang CY. 2004. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet 36:837-841.
11. Hashiguchi K, Ozaki M, Kuraoka I, Saitoh H. 2013. Establishment of a human cell line stably overexpressing mouse Nip45 and characterization of Nip45 subcellular localization. Biochem Biophys Res Commun 430:72-77.
12. Hay RT. 2005. SUMO: a history of modification. Mol Cell 18:1-12.
13. Hochstrasser M. 2009. Origin and function of ubiquitin-like proteins. Nature 458:422-429.
14. Hoppe JB, Rattray M, Tu H, Salbego CG, Cimarosti H. 2013. SUMO-1 conjugation blocks beta-amyloid-induced astrocyte reactivity. Neurosci Lett 546:51-56.
15. Huang Q, Figueiredo-Pereira ME. 2010. Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis 15:1292-1311.
16. Jackson SP, Durocher D. 2013. Regulation of DNA damage responses by ubiquitin and SUMO. Mol Cell 49:795-807.
17. Kawabe H, Brose N. 2011. The role of ubiquitylation in nerve cell development. Nat Rev Neurosci 12:251-268.
18. Knipscheer P, van Dijk WJ, Olsen JV, Mann M, Sixma TK. 2007. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation. EMBO J 26:2797-2807.
19. Kriegstein A, Alvarez-Buylla A. 2009. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci 32:149-184.
20. Krumova P, Weishaupt JH. 2013. Sumoylation in neurodegenerative diseases. Cell Mol Life Sci 70:2123-2138.
21. Lazarov NE. 2002. Comparative analysis of the chemical neuroanatomy of the mammalian trigeminal ganglion and mesencephalic trigeminal nucleus. Prog Neurobiol 66:19-59.
22. Lendahl U, Zimmerman LB, McKay RD. 1990. CNS stem cells express a new class of intermediate filament protein. Cell 60:585-595.
23. Li R, Wei J, Jiang C, Liu D, Deng L, Zhang K, Wang P. 2013. Akt SUMOylation regulates cell proliferation and tumorigenesis. Cancer Res 73:5742-5753.
24. Lomeli H, Vazquez M. 2011. Emerging roles of the SUMO pathway in development. Cell Mol Life Sci 68:4045-4064.
25. Loriol C, Parisot J, Poupon G, Gwizdek C, Martin S. 2012. Developmental regulation and spatiotemporal redistribution of the sumoylation machinery in the rat central nervous system. PLoS One 7:e33757.
26. Luan Z, Liu Y, Stuhlmiller TJ, Marquez J, García-Castro MI. 2013. SUMOylation of Pax7 is essential for neural crest and muscle development. Cell Mol Life Sci 70:1793-1806.
27. Martin S, Nishimune A, Mellor JR, Henley JM. 2007. SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature 447:321-325.
28. Marusich MF, Furneaux HM, Henion PD, Weston JA. 1994. Hu neuronal proteins are expressed in proliferating neurogenic cells. J Neurobiol 25:143-155.
29. Moschos SJ, Jukic DM, Athanassiou C, Bhargava R, Dacic S, Wang X, Kuan SF, Fayewicz SL, Galambos C, Acquafondata M, Dhir R, Becker D. 2010. Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues. Hum Pathol 41:1286-1298.
30. Nacerddine K, Lehembre F, Bhaumik M, Artus J, Cohen-Tannoudji M, Babinet C, Pandolfi PP, Dejean A. 2005. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev Cell 9:769-79.
31. Nakamura Y, Sakakibara S, Miyata T, Ogawa M, Shimazaki T, Weiss S, Kageyama R, Okano H. 2000. The bHLH gene hes1 as a repressor of the neuronal commitment of CNS stem cells. J Neurosci 20:283-293.
32. Newton K, Petfalski E, Tollervey D, Caceres JF. 2003. Fibrillarin is essential for early development and required for accumulation of an intron-encoded small nucleolar RNA in the mouse. Mol Cell Biol 23:8519-8527.
33. Pascale A, Gusev PA, Amadio M, Dottorini T, Govoni S, Alkon DL, Quattrone A. 2004. Increase of the RNA-binding protein HuD and posttranscriptional up-regulation of the GAP-43 gene during spatial memory. Proc Natl Acad Sci U S A 101:1217-1222.
34. Paxinos G, Franklin K. 2012. The mouse brain in stereotaxic coordinates, 4th ed. San Diego: Academic Press.
35. Phair RD, Misteli T. 2000. High mobility of proteins in the mammalian cell nucleus. Nature 404:604-609.
36. Pierfelice TJ, Schreck KC, Dang L, Asnaghi L, Gaiano N, Eberhart CG. 2011. Notch3 activation promotes invasive glioma formation in a tissue site-specific manner. Cancer Res 71:1115-1125.
37. Rossi S, Laurino L, Furlanetto A, Chinellato S, Orvieto E, Canal F, Facchetti F, Dei Tos AP. 2005. Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies. Am J Clin Pathol 124:295-302.
38. Saitoh H, Hinchey J. 2000. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem 275:6252-6258.
39. Sakakibara S, Okano H. 1997. Expression of neural RNA-binding proteins in the postnatal CNS: implications of their roles in neuronal and glial cell development. J Neurosci 17:8300-8312.
40. Sakakibara S, Nakamura Y, Satoh H, Okano H. 2001. RNA-binding protein Musashi2: developmentally regulated expression in neural precursor cells and subpopulations of neurons in mammalian CNS. J Neurosci 21:8091-8107.
41. Scheschonka A, Tang Z, Betz H. 2007. Sumoylation in neurons: nuclear and synaptic roles? Trends Neurosci 30:85-91.
42. Seri B, García-Verdugo JM, Collado-Morente L, McEwen BS, Alvarez-Buylla A. 2004. Cell types, lineage, and architecture of the germinal zone in the adult dentate gyrus. J Comp Neurol 478:359-378.
43. Suh H, Consiglio A, Ray J, Sawai T, D'Amour KA, Gage FH. 2007. In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2+ neural stem cells in the adult hippocampus. Cell Stem Cell 1:515-528.
44. Tahmasebi S, Ghorbani M, Savage P, Yan K, Gocevski G, Xiao L, You L, Yang X. 2013. Sumoylation of Krüppel-like factor 4 inhibits pluripotency induction but promotes adipocyte differentiation. J Biol Chem 288:12791-12804.
45. Tatham MH, Jaffray E, Vaughan OA, Desterro JM, Botting CH, Naismith JH, Hay RT. 2001. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem 276:35368-35374.
46. Tatham MH, Geoffroy MC, Shen L, Plechanovova A, Hattersley N, Jaffray EG, Palvimo JJ, Hay RT. 2008. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol 10:538-546.
47. Tossidou I, Niedenthal R, Klaus M, Teng B, Worthmann K, King BL, Peterson KJ, Haller H, Schiffer M. 2012. CD2AP regulates SUMOylation of CIN85 in podocytes. Mol Cell Biol 32:1068-1079.
48. Tsuruzoe S, Ishihara K, Uchimura Y, Watanabe S, Sekita Y, Aoto T, Saitoh H, Yuasa Y, Niwa H, Kawasuji M, Baba H, Nakao M. 2006. Inhibition of DNA binding of Sox2 by the SUMO conjugation. Biochem Biophys Res Commun 351:920-926.
49. Vertegaal AC, Andersen JS, Ogg SC, Hay RT, Mann M, Lamond AI. 2006. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol Cell Proteomics 5:2298-2310.
50. Watanabe M, Takahashi K, Tomizawa K, Mizusawa H, Takahashi H. 2008. Developmental regulation of Ubc9 in the rat nervous system. Acta Biochim Pol 55:681-686.
51. Wei F, Scholer HR, Atchison ML. 2007. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J Biol Chem 282:21551-21560.
52. Wilkinson KA, Henley JM. 2010. Mechanisms, regulation and consequences of protein SUMOylation. Biochem J 428:133-145.
53. Wong MB, Goodwin J, Norazit A, Meedeniya AC, Richter-Landsberg C, Gai WP, Pountney DL. 2013. SUMO-1 is associated with a subset of lysosomes in glial protein aggregate diseases. Neurotox Res 23:1-21.
54. Wu Y, Guo Z, Wu H, Wang X, Yang L, Shi X, Du J, Tang B, Li W, Yang L, Zhang Y. 2012. SUMOylation represses Nanog expression via modulating transcription factors Oct4 and Sox2. PLoS One 7:e39606.
55. Yang SH, Galanis A, Witty J, Sharrocks AD. 2006. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J 25:5083-5093.
56. Zhang FP, Mikkonen L, Toppari J, Palvimo JJ, Thesleff I, Janne OA. 2008. Sumo-1 function is dispensable in normal mouse development. Mol Cell Biol 28:5381-5390.